Prevalence of Hospital Bacterial Resistance from 2016 to 2018 in Northwest Mexico
Prevalence of Hospital Bacterial Resistance
DOI:
https://doi.org/10.18633/biotecnia.v25i3.2064Keywords:
Antimicrobial resistance; Surveillance; Antibiotics; Antibiogram; E. coli; Mexican hospital.Abstract
In Mexico, antimicrobial resistance, a public health problem, is difficult to address because of the absence of a regulatory body to effectively control the use and sale of antimicrobials; the low surveillance of prescription and self-medication; and the lack of information. This study aimed to determine the prevalence of resistance to antibiotics in bacteria isolated from hospital clinical samples in northwest Mexico. This study consisted of collecting the information from the logs of the cultures that were carried out in the Microbiology area of the Clinical Analysis Laboratory and its resistance to antibiotics, from December 2016 to January 2018, in Hospital in Northwest Mexico. Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus infections were the most common among patients from all care services. Klebsiella pneumonia Pseudomonas aeruginosa, Enterobacter cloacae, S. aureus, Staphylococcus epidermidis, and E. coli showed antibiotic resistance up to 90 and 100%. Benzylpenicillin was the antibiotic to which a high resistance was observed in the intensive care unit service (100%). High bacterial resistance to antibiotics was found from December 2016 to January 2018 in the present study and, in comparison with few Mexican studies, it has remained unchanged.
Downloads
References
Aloraifi, R.I., Alharthi, A.F., Almefleh, A.A., Alamri, A.H., Alobud, A.S., Bawazeer, R.A., Alswaji, A.A., Alalwan, B., Aldriwesh, M.G., Johani, S.M.A., Alghoribi, M.F., Aloraifi, R., Alharthi, A.F., Almefleh, A.A., Alamri, A.H., Alobud, A.S., Bawazeer, R.A., Alswaji, A., Alalwan, B., Aldriwesh, M., Johani, S.M.A., Alghoribi, M.F., 2023. Prevalence of Carbapenem Non-susceptible Gram-Negative Bacteria at Tertiary Care Hospitals in Saudi Arabia. Cureus 15. https://doi.org/10.7759/cureus.33767
Alós, J.I., 2005. Epidemiología y etiología de la infección urinaria comunitaria. Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia. Enferm Infecc Microbiol Clin 23, 3–8.
Bakkeren, E., Diard, M., Hardt, W.-D., 2020. Evolutionary causes and consequences of bacterial antibiotic persistence. Nature Reviews Microbiology 18, 479–490.
Bolado-Martínez, E., Nevárez-López, A.R., Candia-Plata, M. del C., Bolado-Martínez, E., Nevárez-López, A.R., Candia-Plata, M. del C., 2018. Vigilancia de la resistencia bacteriana en instituciones de salud de la ciudad de Hermosillo, Sonora, México. Salud Pública de México 60, 117–119. https://doi.org/10.21149/8560
Borgio, J.F., Rasdan, A.S., Sonbol, B., Alhamid, G., Almandil, N.B., AbdulAzeez, S., 2021. Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula. Biology (Basel) 10, 1144. https://doi.org/10.3390/biology10111144
Castañeda-Martínez, F.C., Valdespino-Padilla, M.G., 2015. Prevalencia de infecciones nosocomiales en un hospital de segundo nivel de atención en México. Rev Med Inst Mex Seguro Soc 53, 686–690.
Ciaglia, E., Lopardo, V., Montella, F., Carrizzo, A., Di Pietro, P., Malavolta, M., Giacconi, R., Orlando, F., Cattaneo, M., Madeddu, P., Vecchione, C., Puca, A.A., 2022. Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38+ macrophages and NAD+ decline. Cell Death Dis 13, 1–10. https://doi.org/10.1038/s41419-022-04535-z
Combes, A., Luyt, C.-E., Trouillet, J.-L., Nieszkowska, A., Chastre, J., 2009. Gender impact on the outcomes of critically ill patients with nosocomial infections. Crit Care Med 37, 2506–2511. https://doi.org/10.1097/CCM.0b013e3181a569df
Duarte-Raya, F., Granados-Ramírez, M.P., 2012. Resistencia antimicrobiana de bacterias en un hospital de tercer nivel. Rev Med Inst Mex Seguro Soc 50, 289–300.
Garza-González, E., Franco-Cendejas, R., Morfín-Otero, R., Echaniz-Aviles, G., Rojas-Larios, F., Bocanegra-Ibarias, P., Flores-Treviño, S., Ponce-de-León, A., Rodríguez-Noriega, E., Alavez-Ramírez, N., Mena-Ramirez, J.P., Rincón-Zuno, J., Fong-Camargo, M.G., Morales-De-la-Peña, C.T., Huerta-Baltazar, C.R., López-Jacome, L.E., Carnalla-Barajas, M.N., Soto-Noguerón, A., Sanchez-Francia, D., Moncada-Barrón, D., Ortíz-Brizuela, E., García-Mendoza, L., Newton-Sánchez, O.A., Choy-Chang, E.V., Aviles-Benitez, L.K., Martínez-Miranda, R., Feliciano-Guzmán, J.M., Peña-Lopez, C.D., Couoh-May, C.A., López-Gutiérrez, E., Gil-Veloz, M., Armenta-Rodríguez, L.C., Manriquez-Reyes, M., Gutierrez-Brito, M., López-Ovilla, I., Adame-Álvarez, C., Barajas-Magallón, J.M., Aguirre-Burciaga, E., Coronado-Ramírez, A.M., Rosales-García, A.A., Sida-Rodríguez, S., Urbina-Rodríguez, R.E., López-Moreno, L.I., Juárez-Velázquez, G.E., Martínez-Villarreal, R.T., Canizales-Oviedo, J.L., Cetina-Umaña, C.M., Perez-Juárez, M.M., González-Moreno, A., Romero-Romero, D., Bello-Pazos, F.D., Aguilar-Orozco, G., Barlandas-Rendón, N.R.E., Maldonado-Anicacio, J.Y., Valadez-Quiroz, A., Camacho-Ortiz, A., 2020. The Evolution of Antimicrobial Resistance in Mexico During the Last Decade: Results from the INVIFAR Group. Microb Drug Resist 26, 1372–1382. https://doi.org/10.1089/mdr.2019.0354
Humphries, D.L., Scott, M.E., n.d. Nutrition and Infectious Diseases.
Kok, M., Maton, L., van der Peet, M., Hankemeier, T., van Hasselt, J.C., 2022. Unraveling antimicrobial resistance using metabolomics. Drug Discovery Today.
Liguori, K., Keenum, I., Davis, B.C., Calarco, J., Milligan, E., Harwood, V.J., Pruden, A., 2022. Antimicrobial resistance monitoring of water environments: a framework for standardized methods and quality control. Environmental science & technology 56, 9149–9160.
Martínez, E.B., Arvizu, A.S.V., Ainza, M.L.Á., Álvarez-Hernández, G., Rangel, M.A.C., Sonora, G. de V. de la R.B. en H., 2022. Vigilancia de la resistencia bacteriana en unidades de salud de Hermosillo y Ciudad Obregón, Sonora, México. Biotecnia 24, 132–139.
Mechanisms of Antibiotic Resistance: QM/MM Modeling of the Acylation Reaction of a Class A β-Lactamase with Benzylpenicillin | Journal of the American Chemical Society [WWW Document], n.d. URL https://pubs.acs.org/doi/10.1021/ja044210d (accessed 1.26.23).
Moisés, R.Z.Rn.N., E, A., Adriana, G.E., Eduardo, R.B., Román, E.L., A, V.C.C., 2013. Alta prevalencia de resistencia a los antibióticos en Escherichia coli uropatógena comunitaria, detectada en hospitales de Hermosillo, Sonora. Enf Infec Microbiol 33, 66–70.
Murrieta, R., Everardo, M., 2018. Evaluación de la resistencia a antibióticos en bacterias recuperadas de muestras clínicas de pacientes de un hospital nivel 2 de Hermosillo, Sonora. Universidad de Sonora.
Patel, J., Harant, A., Fernandes, G., Mwamelo, A.J., Hein, W., Dekker, D., Sridhar, D., 2023. Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries. Lancet Infect Dis S1473-3099(22)00796–4. https://doi.org/10.1016/S1473-3099(22)00796-4
Pishtiwan, A.H., Khadija, K.M., 2019. Prevalence of blaTEM, blaSHV, and blaCTX-M Genes among ESBL-Producing Klebsiella pneumoniae and Escherichia coli Isolated from Thalassemia Patients in Erbil, Iraq. Mediterr J Hematol Infect Dis 11, e2019041. https://doi.org/10.4084/MJHID.2019.041
Rello, J., Kalwaje Eshwara, V., Lagunes, L., Alves, J., Wunderink, R.G., Conway-Morris, A., Rojas, J.N., Alp, E., Zhang, Z., 2019. A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis. Eur J Clin Microbiol Infect Dis 38, 319–323. https://doi.org/10.1007/s10096-018-3428-y
Rolain, J.-M., Abat, C., Jimeno, M.-T., Fournier, P.-E., Raoult, D., 2016. Do we need new antibiotics? Clin Microbiol Infect 22, 408–415. https://doi.org/10.1016/j.cmi.2016.03.012
Romero, R.M., Acosta, D.D.M., Ortega, A.B., 2013. Prevalencia y resistencia antimicrobiana de microorganismos aislados en el Centro Oncológico Estatal del ISSEMYM. Rev Mex Patol Clin Med Lab 60, 244–251.
Salleh, M.Z., Nik Zuraina, N.M.N., Hajissa, K., Ilias, M.I., Deris, Z.Z., 2022. Prevalence of Multidrug-Resistant Diarrheagenic Escherichia coli in Asia: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 11, 1333. https://doi.org/10.3390/antibiotics11101333
Trucco A., O., Prado J., V., Durán T., C., 2002. Red de vigilancia de resistencia antimicrobiana PRONARES: Informe primer semestre 2001. Revista chilena de infectología 19, 140–148. https://doi.org/10.4067/S0716-10182002019200015
Vélez-Pereira, A., Caicedo, Y.C., 2014. Aerobacterias en las unidades de cuidado intensivo del Hospital Universitario Fernando Troconis, Colombia. Revista Cubana de Salud Pública 40, 362–368.
Wilson S., M., Otth L., C., Medina S., G., Otth R., L., Fernández J., H., Arce, M., Zaror C., A., Lizama, V., Gil D., M., Von Chrismar, A.M., 2007. Genotipos de Staphylococcus aureus con fenotipo meticilino resistente, aislados de pacientes del Hospital Base de Valdivia. Rev. méd. Chile 596–601.
Zambrano Gari, C.C., Luna Fontalvo, J.A., 2013. Diversidad microbiana presente en el ambiente de la clínica odontológica de la universidad del Magdalena. Intropica: Revista del Instituto de Investigaciones Tropicales 8, 61–68.
Zarb, P., Coignard, B., Griskeviciene, J., Muller, A., Vankerckhoven, V., Weist, K., Goossens, M., Vaerenberg, S., Hopkins, S., Catry, B., Monnet, D., Goossens, H., Suetens, C., National Contact Points for the ECDC pilot point prevalence survey, Hospital Contact Points for the ECDC pilot point prevalence survey, 2012. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill 17, 20316. https://doi.org/10.2807/ese.17.46.20316-en
Zúniga-Moya, J.C., Bejarano-Cáceres, S., Valenzuela-Cervantes, H., Gough-Coto, S., Castro-Mejía, A., Chinchilla-López, C., Díaz-Mendoza, T., Hernández-Rivera, S., Martínez-López, J., n.d. Perfil de sensibilidad a los antibióticos de las bacterias en infecciones del tracto urinario. Acta Médica Costarricense 58, 146–154.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal Biotecnia is licensed under the Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license.